# Study in Adult Asthmatic Patients With Allergic Bronchopulmonary Aspergillosis

> **NCT03960606** · PHASE2 · TERMINATED · sponsor: **Pulmatrix Inc.** · enrollment: 7 (actual)

## Conditions studied

- Allergic Bronchopulmonary Aspergillosis

## Interventions

- **COMBINATION_PRODUCT:** PUR1900
- **COMBINATION_PRODUCT:** Placebo

## Key facts

- **NCT ID:** NCT03960606
- **Lead sponsor:** Pulmatrix Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-07-31
- **Primary completion:** 2020-07-14
- **Final completion:** 2020-07-14
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** COVID-19 Pandemic
- **Last updated:** 2021-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03960606

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03960606, "Study in Adult Asthmatic Patients With Allergic Bronchopulmonary Aspergillosis". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT03960606. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*